Finance & Investment - Deals

  • Emerald Health acquires Agro-Biotech

    Emerald Health acquires Agro-Biotech

    Nov 15, 2018

    On May 2, 2018, Emerald Health Therapeutics Inc. acquired all of the issued and outstanding securities of 8611165 Canada Inc. (doing business as Agro-Biotech)

  • Aurora Cannabis Inc. acquires Anandia Laboratories Inc.

    Aurora Cannabis Inc. acquires Anandia Laboratories Inc.

    Aug 14, 2018

    On August 14, 2018, Aurora Cannabis Inc. (TSX: ACB) (OTCQB: ACBFF) (Frankfurt: 21P; WKN: A1C4WM) completed its June-announced acquisition of Anandia Laboratories Inc. in an all-stock transaction valued at $118 million pursuant to a court ordered plan of arrangement.

  • Aphria Inc. acquires LATAM Holdings Inc. for US$130M

    Aphria Inc. acquires LATAM Holdings Inc. for US$130M

    Jul 30, 2018

    COLOMBIA - Aphria Inc. of Canada planned to acquire the entire share capital of LATAM Holdings Inc., manufacturer of pharmaceutical preparations, from Scythian Biosciences Corp., for a total COP 376.112 bil (USD 130.887 mil), in a stock swap transaction.

  • Aurora Cannabis completes US$2.5B acquisition of MedReleaf

    Aurora Cannabis completes US$2.5B acquisition of MedReleaf

    Jul 25, 2018

    On July 25, 2018, Aurora Cannabis Inc. completed the acquisition of MedReleaf Corp. in a transaction valued at US$2.5 billion or ($3.2 billion).

  • Canopy Growth establishes BC Tweed

    Canopy Growth establishes BC Tweed

    Jul 5, 2018

    On October 11, 2017, Canopy Growth Corp. (Canopy Growth) entered into a definitive joint venture agreement to form a new company, BC Tweed Joint Venture Inc. (BC Tweed) together with a large-scale greenhouse operator (the Partner) to develop 1.3 million square feet of greenhouse growing capacity in British Columbia.

  • Aurora Cannabis acquires CanniMed Therapeutics

    Aurora Cannabis acquires CanniMed Therapeutics

    May 2, 2018

    On May 2, 2018, Aurora Cannabis (TSX:ACB) (OTCQB:ACBFF) (Frankfurt: 21P; WKN:A1C4WM) completed its $1.23 billion (US$950 million) takeover bid for all of the outstanding shares CanniMed Therapeutics Inc. (TSX: CMED).

  • Aphria Inc. acquires Nuuvera Inc.

    Aphria Inc. acquires Nuuvera Inc.

    Mar 23, 2018

    On March 23, 2018, Aphria Inc. (Aphria)(TSX: APH and US OTC: APHQF) completed its acquisition of Nuuvera Inc. (Nuuvera) pursuant to a plan of arrangement under the Business Corporations Act (Ontario) for approximately $425 million.

  • Cannabis Strategies Acquisition Corp. completes IPO

    Cannabis Strategies Acquisition Corp. completes IPO

    Dec 21, 2017

    Cannabis Strategies Acquisition Corp. (CSAC), and Mercer Park CB, LP as sponsor, completed the initial public offering of Class A restricted voting units of CSAC (including the partial exercise of the over-allotment option) for an aggregate of $134,750,000.

  • Canopy Growth establishes new collaboration with Green House and Organa Brands

    Canopy Growth establishes new collaboration with Green House and Organa Brands

    Dec 1, 2017

    On December 1, 2017, Canopy Growth Corp. (Canopy Growth), Green House Holdings North America Inc. (Green House) and its affiliate in the Netherlands, GHSC Trading B.V., National Concessions Group Inc. (Organa Brands) entered into a collaborative joint venture.

  • MedReleaf Corp. completes $100M initial public offering and secondary offering

    MedReleaf Corp. completes $100M initial public offering and secondary offering

    Jun 7, 2017

    On June 7, 2017, MedReleaf Corp. (MedReleaf) completed its initial public offering and secondary offering (collectively, the Offering) of an aggregate of 10,600,000 common shares for aggregate gross proceeds of $100,700,000, with MedReleaf and certain shareholders (the Selling Shareholders) receiving gross proceeds of $80,700,049 and $19,999,951, respectively.

  • Village Farms and Emerald Health form joint venture

    Village Farms and Emerald Health form joint venture

    Jun 6, 2017

    On June 6, 2017, Village Farms International, Inc. (Village Farms) and Emerald Health Therapeutics Inc., together with its affiliates (Emerald), entered into a definitive agreement to form a joint venture for large-scale, high-quality, low-cost cannabis production. Under the terms of the agreement, Village Farms initially contributed a 1.1-million square-foot greenhouse facility in Delta, BC.

  • Mettrum Health Corp. completes sale to Canopy Growth Corp.

    Mettrum Health Corp. completes sale to Canopy Growth Corp.

    Jan 31, 2017

    Mettrum Health Corp. (Mettrum) completed the sale of all of its issued and outstanding shares to Canopy Growth Corporation (Canopy) by plan of arrangement, whereby Mettrum shareholders received 0.7132 common shares of Canopy for each Mettrum common share held, representing consideration of $8.42 per common share and a total transaction value of approximately $430 million, based on the respective closing prices prior to announcement of the transaction.